A tighter archive for life-science signals.
Search once, then narrow by source or topic.
<a href="https://www.fiercebiotech.com/biotech/modernas-reshaping-rolls-3-more-pipeline-purges" hreflang="en">Moderna's reshaping rolls on with 3 more pipeline purges</a>
Moderna, an mRNA specialist known for its COVID-19 vaccine Spikevax, is winding down development of three clinical mRNA programs, including two investigational vaccines...
What’s next in the eye disease pipeline?
What’s next in the eye disease pipeline? An early gene therapy breakthrough spurred investments, but can the industry maintain momentum? Published Nov. 24, 2025 By Kell...
Roche touts early giredestrant success | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Roche touts early giredestrant success | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? - simplywall.st
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? simplywall.st
Roche Earnings: We’re Slightly Lowering Our 2025 Sales Forecast but Encouraged by Diverse Pipeline - Morningstar Canada
Roche Earnings: We’re Slightly Lowering Our 2025 Sales Forecast but Encouraged by Diverse Pipeline Morningstar Canada
Roche pushes a novel myeloma target | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Roche pushes a novel myeloma target | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Roche looks earlier with divarasib | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Roche looks earlier with divarasib | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
5,000 patients later Roche scraps its TIGIT | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
5,000 patients later Roche scraps its TIGIT | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page